603987.SH
康德莱
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 7.46
−0.27%Year over year
Reported trailing growth
- Revenue
- +2.1%
- EBITDA
- —
- EBIT
- +20.3%
- EPS
- +7.4%
- Free cash flow
- +47.4%
- Operating cash flow
- +22.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -9.7%
- EBITDA
- -5.2%
- EBIT
- -8.0%
- Net income
- -8.3%
- EPS
- -8.2%
- Free cash flow
- +16.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026